Stock CDIO CARDIO DIAGNOSTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cardio Diagnostics Holdings, Inc.

Equities

CDIO

US14159C1036

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 02:11:04 2024-06-11 pm EDT 		5-day change 1st Jan Change
0.582 USD -6.13% Intraday chart for Cardio Diagnostics Holdings, Inc. -14.28% -76.07%
Jun. 06 Benchmark Raises Price Target on Cardio Diagnostics to $2 From $1.35, Maintains Speculative Buy Rating MT
May. 15 Cardio Diagnostics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 10.09 51.09 14.07 -
Enterprise Value (EV) 1 10.09 51.09 14.07 14.07
P/E ratio -0.7 x -3.77 x -1.35 x -1.68 x
Yield - - - -
Capitalization / Revenue 10,616 x 2,993 x 27.3 x 7.81 x
EV / Revenue 10,616 x 2,993 x 27.3 x 7.81 x
EV / EBITDA - - - -
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 9,515 20,517 22,686 -
Reference price 2 1.060 2.490 0.6200 0.6200
Announcement Date 3/31/23 4/1/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 0.00095 0.0171 0.516 1.8
EBITDA - - - -
EBIT 1 -4.548 -7.242 -9.586 -8.132
Operating Margin -478,784.21% -42,428% -1,857.75% -451.78%
Earnings before Tax (EBT) 1 -4.661 -8.377 -9.591 -8.132
Net income 1 -4.661 -8.377 -9.591 -8.132
Net margin -490,630.53% -49,073.4% -1,858.72% -451.78%
EPS 2 -1.510 -0.6600 -0.4600 -0.3700
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 3/31/23 4/1/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - - 0.00095 - 0.00173 0.01 0.00531 0.0159 0.1 0.15 0.25 0.35 0.45
EBITDA - - - - - - - - - - - - -
EBIT 1 - -0.1653 -2.378 -1.703 -2.553 -1.444 -1.542 -4.158 -1.847 -1.746 -1.835 -2.008 -2.096
Operating Margin - - -250,322.11% - -147,580.35% -14,398.7% -29,039.55% -26,102.01% -1,847% -1,164% -734% -573.71% -465.78%
Earnings before Tax (EBT) 1 - 0.2023 -2.378 -1.033 -4.023 -1.932 -1.389 -4.164 -1.847 -1.746 -1.835 -2.008 -2.096
Net income 1 -0.842 0.2023 -2.378 -1.033 -4.023 -1.932 -1.389 -4.164 -1.847 -1.746 -1.835 -2.008 -2.096
Net margin - - -250,322.11% - -232,538.15% -19,266% -26,156.87% -26,136.72% -1,847% -1,164% -734% -573.71% -465.78%
EPS 2 -0.5300 0.0200 -0.0600 -0.1100 -0.3900 -0.1600 - -0.2000 -0.0900 -0.0800 -0.0900 -0.0900 -0.0900
Dividend per Share - - - - - - - - - - - - -
Announcement Date 8/23/22 11/7/22 3/31/23 5/15/23 8/14/23 11/13/23 4/1/24 5/15/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex 1 - - 0.4 0.5
Capex / Sales - - 76.55% 27.78%
Announcement Date 3/31/23 4/1/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Cardio Diagnostics Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.62 USD
Average target price
5 USD
Spread / Average Target
+706.45%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CARDIO DIAGNOSTICS HOLDINGS, INC. Stock Cardio Diagnostics Holdings, Inc.
-76.07% 14.07M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+18.41% 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+15.41% 108B
BIONTECH SE Stock BioNTech SE
-6.71% 23.64B
ARGENX SE Stock argenx SE
+2.39% 22.39B
GENMAB A/S Stock Genmab A/S
-12.11% 17.78B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.64% 16.43B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.55% 16.34B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.39% 13.56B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+24.68% 11.59B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. CDIO Stock
  4. Financials Cardio Diagnostics Holdings, Inc.